Explore the vast range of titles available.

What is a natural forest disturbance? How well do we understand natural forest disturbances and how might we emulate them in forest management? What role does emulation play in forest management? Representing a range of geographic perspectives from across Canada and the United States, this book looks at the escalating public debate on the viability of natural disturbance emulation for sustaining forest landscapes from the perspective of policymakers, forestry professionals, academics, and conservationists. This book provides a scientific foundation for justifying the use of and a solid framework for examining the ambiguities inherent in emulating natural forest landscape disturbance. It acknowledges the divergent expectations that practitioners face and offers a balanced view of the promises and challenges associated with applying this emerging forest management paradigm.

The boreal forest is the largest forest region in Canada, occupying approximately 315 mill. ha. Within this forest region long-term average annual area burned is 1.3 mill. ha, with extreme fire years being common, covering up to 7 million ha in a single fire season. Only 2% to 3% of those fires that cover more than 200 ha eventually contribute about 98% of the total area burned annually. Careful examination of fire statistics seems to indicate that fire occurrence is increasing in the boreal forest. Boreal forest tree species and ecosystems are adapted to the periodic passage of fire and some would disappear as natural components of the landscape in the absence of fire. Use of fire as a management tool recognizes the natural role of fire and is applied judiciously for ecosystem maintenance and restoration in selected areas. Implications of possible anthropogenically generated climate change are examined within the context of sustainability of the boreal forest biome and the anticipated impact on fire regime and fire management.

\"This book provides a scientific foundation for justifying the use of and a solid framework for examining the ambiguities inherent in emulating natural forest landscape disturbance. It acknowledges the divergent expectations that practitioners face and offers a balanced-view of the promises and challenges associated with applying this emerging forest management paradigm.\"--Jacket.

In this chapter, we present a synthesis of the state of knowledge about emulating natural disturbance in northern North America and provide a view of the future of this forest management approach. We summarize the information presented in the other chapters of this book to describe what natural disturbance emulation is, why one might do it, methods of understanding natural disturbance, and practical approaches to implementing this concept. In addition, we present the status of emulating natural disturbance from the perspective of forest practitioners and stakeholders, and describe the general challenges they face in doing so. Finally, we highlight future

It began in July 1993, when then-Budget Director Ronald S. Rubino went searching for ways to patch the hole left by the loss of state funds, prosecutors allege. He hatched a plan with his old buddy Citron and then-Assistant Treasurer Matthew Raabe, they claim, to siphon off the interest earnings of other investors and stash them in a rainy-day fund that would one day grow to roughly $150 million. \"{Rubino} said that Mr. Citron had been doing a tremendous job earning interest over the last 20 years, and that the {other} people who were in the fund were being very well rewarded,\" Raabe testified. In April, Citron received a telephone call from an attorney on the staff of the U.S. Securities and Exchange Commission in Los Angeles. After the call, Citron \"was very concerned and he was nervous,\" testified lobbyist Lyle A. Overby, who advised Citron on how to handle attacks from Moorlach.

To the delight of county officials, Citron came up with yet another way of producing cash at a time when the Legislature was taking it away. While other counties dealt with the harsh budgetary realities of the early 1990s, Orange County officials didn't question their good fortune or the \"genius\" who supplied it. It began in July 1993, when then-Budget Director Ronald S. Rubino went searching for ways to patch the hole left by the loss of state funds, prosecutors alleged. He hatched a plan with his old buddy Citron and then-Assistant Treasurer Matthew R. Raabe, prosecutors maintained, to siphon off the interest earnings of investors in the county pool and stash them in a rainy day fund that would one day grow to about $150 million. \"{Rubino} said that Mr. Citron had been doing a tremendous job earning interest over the last 20 years, and that the {other} people who were in the fund were being very well rewarded,\" Raabe testified.

The role of temozolomide chemotherapy in newly diagnosed 1p/19q non-co-deleted anaplastic gliomas, which are associated with lower sensitivity to chemotherapy and worse prognosis than 1p/19q co-deleted tumours, is unclear. We assessed the use of radiotherapy with concurrent and adjuvant temozolomide in adults with non-co-deleted anaplastic gliomas. This was a phase 3, randomised, open-label study with a 2 × 2 factorial design. Eligible patients were aged 18 years or older and had newly diagnosed non-co-deleted anaplastic glioma with WHO performance status scores of 0–2. The randomisation schedule was generated with the electronic EORTC web-based ORTA system. Patients were assigned in equal numbers (1:1:1:1), using the minimisation technique, to receive radiotherapy (59·4 Gy in 33 fractions of 1·8 Gy) alone or with adjuvant temozolomide (12 4-week cycles of 150–200 mg/m2 temozolomide given on days 1–5); or to receive radiotherapy with concurrent temozolomide 75 mg/m2 per day, with or without adjuvant temozolomide. The primary endpoint was overall survival adjusted for performance status score, age, 1p loss of heterozygosity, presence of oligodendroglial elements, and MGMT promoter methylation status, analysed by intention to treat. We did a planned interim analysis after 219 (41%) deaths had occurred to test the null hypothesis of no efficacy (threshold for rejection p<0·0084). This trial is registered with ClinicalTrials.gov, number NCT00626990. At the time of the interim analysis, 745 (99%) of the planned 748 patients had been enrolled. The hazard ratio for overall survival with use of adjuvant temozolomide was 0·65 (99·145% CI 0·45–0·93). Overall survival at 5 years was 55·9% (95% CI 47·2–63·8) with and 44·1% (36·3–51·6) without adjuvant temozolomide. Grade 3–4 adverse events were seen in 8–12% of 549 patients assigned temozolomide, and were mainly haematological and reversible. Adjuvant temozolomide chemotherapy was associated with a significant survival benefit in patients with newly diagnosed non-co-deleted anaplastic glioma. Further analysis of the role of concurrent temozolomide treatment and molecular factors is needed. Schering Plough and MSD.